Small study seeks best numbing dose for skin surgery
NCT ID NCT06694714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing how long two different volumes of a common numbing medicine (lidocaine with epinephrine) keep the skin numb during dermatologic surgery. Researchers will inject either 0.5 ml or 1.0 ml into the side of the nose in 35 adults and check every 15 minutes when feeling returns. The goal is to see if a larger volume provides a meaningfully longer numbing effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lidocaine with epinephrine
What this could lead to
If successful, this could help doctors choose the best anesthetic volume for numbing highly vascular skin areas, improving patient comfort during minor surgery.
What could go wrong
This is a small, early-phase study (35 participants) focused on measuring numbness duration, not on treating a disease. Results may not apply to other body sites or anesthetics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA, LOCAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact